Literature DB >> 34148218

HPV-Associated Anal Cancer Knowledge, Attitudes, and Health Communication Behaviors Among Non-clinical Providers at HIV/AIDS Service Organizations in Southern United States Region.

Olufunto A Olusanya1, Aditi Tomar2, Jonathan Thomas3, Praisy Johnson3, Lisa T Wigfall4.   

Abstract

Co-infection with HIV/HPV and bio-behavioral risk factors (e.g., immunodeficiency, un-protected sex) increase likelihood for developing anal and other HPV-associated cancers among people living with HIV/AIDS (PLWHA). We explored knowledge, attitudes, and health communication regarding HPV-associated anal cancers among HIV/AIDS service organization (ASO) employees/volunteers delivering non-clinical services to PLWHA. Participants (n=59) were recruited from six ASOs located in the South United States Census region and completed a 118-item self-administered survey. For current analyses, outcome measures were knowledge, attitudes, and health communication regarding anal cancer. Descriptive statistics assessed outcome measures which were subsequently dichotomized into binary variables (i.e., high/favorable or low/unfavorable). Fisher's exact test examined associations between outcome measures and ASO employees/volunteers' sex/sexual orientation (i.e., heterosexual female, heterosexual male, LGBTI female, LGBTI male). Mean age for ASO employees/volunteers was 45.5 years (±13.5 SD). Participants were heterosexual females (45.7%), LGBTI males (27.3%), heterosexual males (13.5%), and LGBTI females (13.5%). Almost half (44.8%) had not heard about anal Pap screening and 39.0% did not think HPV can cause anal cancer. Overall, 73.9% had low knowledge scores. Participants (47.4%) were unsure or believed HPV vaccinations were non-protective against anal cancer while 94.9% had favorable health communication behaviors. Knowledge regarding anal cancer being linked to HPV (p=0.006) and health information seeking on anal cancer (p=0.000) were statistically significantly different by sex/sexual orientation. Fostering increased knowledge, favorable attitudes, and improved health communication behaviors among ASO employees/volunteers could facilitate dissemination and promotion of anal cancer prevention strategies (anal Pap screenings, HPV vaccinations) among PLWHA.

Entities:  

Keywords:  Anal cancer; Anal cancer screenings; Health communication; Human immunodeficiency virus (HIV); Human papillomavirus (HPV); Knowledge; Vaccinations

Year:  2021        PMID: 34148218      PMCID: PMC8685300          DOI: 10.1007/s13187-021-02056-5

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  15 in total

1.  Type-Specific Anal Human Papillomavirus Prevalence Among Men, According to Sexual Preference and HIV Status: A Systematic Literature Review and Meta-Analysis.

Authors:  Elske Marra; Chunqing Lin; Gary M Clifford
Journal:  J Infect Dis       Date:  2019-01-29       Impact factor: 5.226

2.  Prevalence of and Risk Factors for Anal High-grade Squamous Intraepithelial Lesions in Women Living with Human Immunodeficiency Virus.

Authors:  Elizabeth A Stier; Shelly Y Lensing; Teresa M Darragh; Ashish A Deshmukh; Mark H Einstein; Joel M Palefsky; Naomi Jay; J Michael Berry-Lawhorn; Timothy Wilkin; Dorothy J Wiley; Luis F Barroso; Ross D Cranston; Rebecca Levine; Humberto M Guiot; Audrey L French; Deborah Citron; M Katayoon Rezaei; Stephen E Goldstone; Elizabeth Chiao
Journal:  Clin Infect Dis       Date:  2020-04-10       Impact factor: 9.079

3.  Anal Cancer Risk Among People With HIV Infection in the United States.

Authors:  Vivian Colón-López; Meredith S Shiels; Mark Machin; Ana P Ortiz; Howard Strickler; Philip E Castle; Ruth M Pfeiffer; Eric A Engels
Journal:  J Clin Oncol       Date:  2017-11-15       Impact factor: 44.544

Review 4.  Human papillomavirus-associated anal and cervical cancers in HIV-infected individuals: incidence and prevention in the antiretroviral therapy era.

Authors:  Joel M Palefsky
Journal:  Curr Opin HIV AIDS       Date:  2017-01       Impact factor: 4.283

5.  Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America.

Authors:  Michael J Silverberg; Bryan Lau; Amy C Justice; Eric Engels; M John Gill; James J Goedert; Gregory D Kirk; Gypsyamber D'Souza; Ronald J Bosch; John T Brooks; Sonia Napravnik; Nancy A Hessol; Lisa P Jacobson; Mari M Kitahata; Marina B Klein; Richard D Moore; Benigno Rodriguez; Sean B Rourke; Michael S Saag; Timothy R Sterling; Kelly A Gebo; Natasha Press; Jeffrey N Martin; Robert Dubrow
Journal:  Clin Infect Dis       Date:  2012-01-30       Impact factor: 9.079

6.  Incidence of HIV-related anal cancer remains increased despite long-term combined antiretroviral treatment: results from the french hospital database on HIV.

Authors:  Christophe Piketty; Hana Selinger-Leneman; Anne-Marie Bouvier; Aurelien Belot; Murielle Mary-Krause; Claudine Duvivier; Manuela Bonmarchand; Laurent Abramowitz; Dominique Costagliola; Sophie Grabar
Journal:  J Clin Oncol       Date:  2012-10-22       Impact factor: 44.544

7.  HPV-associated oropharyngeal cancer: Knowledge and attitude/beliefs among non-clinical staff at community-based HIV/AIDS Service Organizations (ASO) in the south United States (U.S.) census region.

Authors:  Aditi Tomar; Hannah C Balcezak; Lisa T Wigfall
Journal:  Health Soc Care Community       Date:  2020-05-28

8.  Hazard of Cervical, Oropharyngeal, and Anal Cancers in HIV-Infected and HIV-Uninfected Medicaid Beneficiaries.

Authors:  Joanne M Michaud; Tingting Zhang; Theresa I Shireman; Yoojin Lee; Ira B Wilson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-05-08       Impact factor: 4.090

9.  Increased risk of anal squamous cell carcinoma in HIV-positive men with prior hepatitis B virus infection.

Authors:  Jordan Aldersley; David R Lorenz; Vikas Misra; Hajime Uno; Dana Gabuzda
Journal:  AIDS       Date:  2019-01-27       Impact factor: 4.177

10.  HPV-Related Cancer Prevention and Control Programs at Community-Based HIV/AIDS Service Organizations: Implications for Future Engagement.

Authors:  Lisa T Wigfall; Shalanda A Bynum; Heather M Brandt; Neethu Sebastian; Marcia G Ory
Journal:  Front Oncol       Date:  2018-10-26       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.